Section Arrow
Quote
TRIB.NASDAQ
- Trinity Biotech plc
(Financial Status)
Quotes are at least 15-min delayed:2025/06/28 13:14 EDT
Last
 0.652
-0.026 (-3.83%)
Day High 
0.772 
Prev. Close
0.678 
1-M High
0.865 
Volume 
412.15K 
Bid
0.6521
Ask
0.7
Day Low
0.645 
Open
0.66 
1-M Low
0.537301 
Market Cap 
12.63M 
Currency USD 
P/E 0.55 
%Yield 33.74 
10-SMA 0.64 
20-SMA 0.64 
50-SMA 0.69 
52-W High 3.44 
52-W Low 0.48 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.80/-0.49
Enterprise Value
110.90M
Balance Sheet
Book Value Per Share
-1.89
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
61.56M
Operating Revenue Per Share
3.89
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed：2025/06/28 13:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.